SCHEMBL24421

SCHEMBL24421

CCCC(=O)OC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28952344 0.97 ALDH1A1 (0.70)
SCHEMBL11209670 0.97 ALDH1A1 (0.70)
SCHEMBL9179052 0.97 ALDH1A1 (0.70)
SCHEMBL2785670 0.97 ALDH1A1 (0.70)
SCHEMBL29071844 0.97
SCHEMBL17159928 0.97 ALDH1A1 (0.70)
SCHEMBL5502285 0.97 ALDH1A1 (0.70)
SCHEMBL28171319 0.97 ALDH1A1 (0.70)
SCHEMBL21753843 0.97 ALDH1A1 (0.70)
SCHEMBL28156012 0.97 ALDH1A1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 102035 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325717-A1 ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-10-23 US claimed
US-20250313647-A1 MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-10-09 US claimed
US-12285494-B2 Methods for treating B-ALL by administering a pre-BCR complex antagonist CHILDREN'S HEALTH CARE (US) 2025-04-29 US claimed
EP-4514857-A2 ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES The Children's Medical Center Corporation (US) 2025-03-05 EP claimed
EP-4514858-A2 MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE The Children's Medical Center Corporation (US) 2025-03-05 EP claimed
WO-2024261409-A1 QUICK AND DIRECT LIGNIN-ESTERIFICATION FOR VARYING APPLICATIONS AALTO UNIVERSITY FOUNDATION SR (FI) 2024-12-26 WO claimed
US-20240384269-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSIOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2024-11-21 US claimed
US-12046756-B2 Cellulose derivative composition for secondary battery binder and method of preparing composition for secondary battery electrode comprising the same ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2024-07-23 US claimed
CN-118368994-A Aerosol-generating material comprising chitosan and other binders 尼科创业贸易有限公司 2024-07-19 CN claimed
WO-2024149292-A1 BLOOD VESSEL CLOSING ADHESIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 苏州美创医疗科技有限公司 2024-07-18 WO claimed
US-3950284-A VINYL POLYMERS, GRAFT OR BLOCK POLYMERS TORAY INDUSTRIES, INC. (JA) 1976-04-13 US claimed
US-3948674-A AN ACRYLIC HOMO- OR CO-POLYMER MONSANTO COMPANY (US) 1976-04-06 US claimed
US-3943063-A Preparation of microcapsules TOYO JOZO COMPANY, LTD. (JA) 1976-03-09 US claimed
US-3941596-A Thermographic processes using polymer layer capable of existing in metastable state E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-03-02 US claimed
US-3938515-A Novel drug permeable wall ALZA CORPORATION (US) 1976-02-17 US claimed
US-3937508-A Vehicle body and bumper assembly FORD MOTOR COMPANY (US) 1976-02-10 US claimed
US-3935334-A Process for preparing a metallized resin film for condenser element OIKE & COMPANY, LTD. (JA) 1976-01-27 US claimed
US-3933508-A ORGANIC SILVER SALT, SILVER HALIDE, REDUCING AGENT, BINDER FUJI PHOTO FILM CO., LTD. (JA) 1976-01-20 US claimed
US-3932250-A Method for manufacturing metal foil- or plastic film-overlaid laminate MITSUBISHI GAS CHEMICAL CO., LTD. (JA) 1976-01-13 US claimed
US-3932191-A WATER AND POLYCARBOXYLIC ACID RESINS PPG INDUSTRIES, INC. (US) 1976-01-13 US claimed